Costs Rs 60,000 per Dose, New Antibody Therapy Can Reduce Hospitalisations, Says Dr Naresh Trehan
The Central Drugs Standards Control Organisation (CDSCO) recently provided an emergency use authorisation (EUA) for the Antibody Cocktail to be made available in India by pharma giant Cipla.
from Top India News- News18.com https://ift.tt/2SAXsgE
via IFTTT
from Top India News- News18.com https://ift.tt/2SAXsgE
via IFTTT
ليست هناك تعليقات